Publicaciones en las que colabora con Ana Rouzaut Subirá (9)

2022

  1. Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy

    Cancer research, Vol. 82, Núm. 23, pp. 4373-4385

2017

  1. Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium

    International Journal of Radiation Oncology Biology Physics, Vol. 97, Núm. 2, pp. 389-400

2016

  1. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer

    Molecular Oncology, Vol. 10, Núm. 9, pp. 1437-1449

2014

  1. TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients

    British Journal of Cancer, Vol. 110, Núm. 6, pp. 1545-1551

2013

  1. Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC

    International Journal of Cancer, Vol. 132, Núm. 9, pp. 1986-1995

2012

  1. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression

    Journal of Immunology, Vol. 189, Núm. 9, pp. 4674-4683

2008

  1. Analysis of TGFBI overexpression and silencing in the proliferation, migration and chemoresistance of NSCLC cells

    EJC SUPPLEMENTS

2007

  1. Lymphangiogenesis and lung cancer

    Journal of Thoracic Oncology, Vol. 2, Núm. 5, pp. 384-386

2005

  1. Targeting hypoxia and angiogenesis through HIF-1α inhibition

    Cancer Biology and Therapy, Vol. 4, Núm. 10, pp. 1055-1062